Malaria diagnosis and treatment in a rural health centre in Mayotte (Comoro archipelago, 2002);Le diagnostic et le traitement des accès palustres dans un dispensaire rural à Mayotte (Archipel des Comores) en 2002

Cahiers Sante

Volumn 14, Issue 1, 2004, Pages 5-10

  Lepère, Jean François ^a   Macarry, Annie ^a  

^a Dispensaire de Bandraboua ^*  (Mayotte)

Author keywords

Chloroquine; Comores; Diagnostic; Fansidar ; Malaria; Mayotte

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; CHLOROQUINE; FANSIDAR; QUININE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; MAYOTTE; PRACTICE GUIDELINE; RURAL HEALTH CARE; TREATMENT FAILURE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COMOROS; FEMALE; HUMANS; MALARIA; MALE; MIDDLE AGED; RURAL POPULATION;

EID: 19244369279     PISSN: 11575999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Julvez J, Blanchy S. Le paludisme dans les îles de l'archipel des Comores. Bull Soc Pathol Exot 1988; 81: 847-53.
2. Blanchy S. État sanitaire de Mayotte en 1981. Bull Soc Pathol Exot 1983; 76: 95-100.
3. Galtier J, Blanchy S. Le paludisme à Mayotte et son évolution de 1976 à 1981. Cah Orstom, Sér Ent méd et Parasitol 1982; 20: 145-51.
4. Julvez J, Galtier J, Ali Halidi M, Henry M, Mouchet J. Epidémiologie du, paludisme et lutte antipaludique à Mayotte. Évolution de la situation de 1976 à 1986. Perspectives. Bull Soc Pathol Exot 1987; 80: 505-19.
5. El-Amine Ali Halidi M. Le paludisme à Mayotte: passé, présent et futur. Cahiers Santé 1995; 5: 362-7.
6. Eichenlaub D, Pohle HD. A case of chloroquine-resistant (R1) falciparum malaria from the East African Comoros Islands. Infection 1980; 8: 90-2.
7. Blanchy S, Benthein F. Chimiosensibilité in vivo de Plasmodium falciparum en République fédérale islamique des Comores. Bull Soc Pathol Exot 1989; 82: 493-502.
8. Feillet N, Agnamey P, Brasseur P, Druilhe P. Résistance in vivo à la chloroquine de Plasmodium falciparum à Anjouan (Comores). Bull Soc Pathol Exot 1993; 86: 48-51.
9. Le Bras J, Simon F, Ramanamirija JA, et al. Sensibilité de Plasmodium falciparum aux quinoléines et stratégies thérapeutiques: comparaison de la situation en Afrique et à Madagascar entre 1983 et 1986. Bull Soc Pathol Exot 1987; 80: 477-89.
10. Rabenjarson E, Keundjian A, Ringwald P, Fadat G, Doury JC, Le Bras J. Chimiosensibilité du paludisme d'importation à Plasmodium falciparum en France en 1991. BEH 1992; 28: 128-30.
11. Ariey F, Randrianarivelojosia M, Duchemin JB, et al. Mapping of a Plasmodium falciparum pfcrt K76T mutation: A useful strategy for controlling chloroquine resistance in Madagascar. J Infect Dis 2002; 185: 710-2.
12. Durand R, Jafari S, Bouchaud O, Ralaimazava P, Keundjian A, Le Bras J. Plasmodium falciparum: pfcrt and dhfr mutations are associated with failure of chloroquine plus proguanil prophilaxis travelers. J Infect Dis 2001; 184: 1633-4.
13. Julvez J, Galtier J. Étude in vivo de la chloroquinoré sistance du paludisme à Plasmodium falciparum à Mayotte. Med Trop 1989; 49: 63-5.
14. Roussin JM, Huart V, Lepère JF, Le Bras MJ, Roussin C, Le Bras J. Dépistage rapide du paludisme et génotypes de chimioré sistance de P. falciparum à Mayotte en 2001. Presse Med 2002; 31: 1312.
15. WHO. Communicable Diseases Cluster. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000, 94 (suppl. 1): S1-S90.
16. Antimalarial drug combination therapy. Report of a WHO Scientific Group. Geneva: World Health Organization, 2001; 36 p.
17. New perspectives. Malaria diagnosis. Report of a joint WHO/USAID informal consultation. Geneva: World Health Organization, 2000; 57 p.
18. Tarimo DS, Minjas JN, Bygbjerg IC. Malaria diagnosis and treatment under the strategy of the integrated management of childhood illness (IMCI): Relevance of laboratory support from the rapid immunochromatographic tests of ICT Malaria P.f/P.v and OptiMAL. Ann Trop Med Parasitol 2001; 95: 437-44.
19. Palmer CJ, Lindo JF, Klaskala WI, et al. Evaluation of the OptiMAL® test for rapid diagnosis of Plasmodium vivax and Plasmodium falciparum malaria. J Clin Microbiol 1998; 36: 203-6.
20. Ferro BE, Gonzalez IJ, Carvajal F, Palma GI, Saravia NG. Performance of OptiMAL® in diagnosis of Plasmodium vivax and Plasmodium falciparum infections in a malaria referral center in Colombia. Mem Inst Oswaldo Cruz 2002; 97: 731-5.
21. Piper R, Le Bras J, Wentworth L, et al. Immunocapture diagnostic assays for malaria using Plasmodium lactate dehydrogenase (pLDH). Am J Trop Med Hyg 1999; 60: 109-18.
22. Coleman RE, Maneechai N, Ponlawat A, et al. Failure of the OptiMAL® rapid malaria test as a tool for the detection of asymptomatic malaria in an area of Thailand endemic for Plasmodium falciparum and P. vivax. Am J Trop Med Hyg 2002; 67: 563-5.
23. Moody AH, Chiodini PL. Non-microscopic method for malaria diagnosis using OptiMAL® IT, a second-generation dipstick for malaria pLDH antigen detection. Br J Biomed Sci 2002; 59: 228-31.
24. The use of antimalarial drugs. Report of a WHO Informal Consultation. Geneva: World Health Organization, 2001; 144 p.
25. Bojang KA, Schneider G, Forck S, et al. A trial of Fansidar plus chloroquine or Fansidar alone for the treatment of uncomplicated malaria in Gambian children. Trans R Soc Trop Med Hyg 1998; 92: 73-6.
26. Ronn AM, Msangeni HA, Mhina J, Wernsdorfer WH, Bygbjerg IC. High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Trans R Soc Trop Med Hyg 1996; 90: 179-81.
27. Sibley CH, Hyde JE, Sims PF, et al. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: What next? Trends Parasitol 2001; 17: 582-8.
28. Tall A, Raharimalala LA, Lepère JF, et al. Efficiency of artemether-lumefantrine treatment in patients with acute uncomplicated falciparum malaria in Mayotte, a French collectivity of the Comoros archipelago. Am J Trop Med Hyg 2003 (submitted).